WO2002000884A3 - Sequence de nucleotides du genome influenza a/udorn/72 (h3n2) - Google Patents

Sequence de nucleotides du genome influenza a/udorn/72 (h3n2) Download PDF

Info

Publication number
WO2002000884A3
WO2002000884A3 PCT/US2001/019826 US0119826W WO0200884A3 WO 2002000884 A3 WO2002000884 A3 WO 2002000884A3 US 0119826 W US0119826 W US 0119826W WO 0200884 A3 WO0200884 A3 WO 0200884A3
Authority
WO
WIPO (PCT)
Prior art keywords
influenza
udorn
genome
nucleotide sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/019826
Other languages
English (en)
Other versions
WO2002000884A2 (fr
Inventor
Jose M Galarza
Theresa E Latham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to AU2001270033A priority Critical patent/AU2001270033A1/en
Priority to IL15300501A priority patent/IL153005A0/xx
Priority to JP2002506199A priority patent/JP2004514415A/ja
Priority to BR0111819-6A priority patent/BR0111819A/pt
Priority to CA002410284A priority patent/CA2410284A1/fr
Priority to EP01948565A priority patent/EP1292614A2/fr
Priority to MXPA02012255A priority patent/MXPA02012255A/es
Publication of WO2002000884A2 publication Critical patent/WO2002000884A2/fr
Publication of WO2002000884A3 publication Critical patent/WO2002000884A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)

Abstract

L'invention concerne la séquence complète des nucléotides de chacun des huit segments de la souche A/Udorn/72 (H3N2) du virus Influenza A à brin négatif, ladite séquence produisant la séquence complète du génome dans un sens de message antigénomique. La séquence est utilisée au cours de diagnostics et peut être modifiée par mutation pour engendrer de nouvelles souches variantes d'Influenza A.
PCT/US2001/019826 2000-06-23 2001-06-21 Sequence de nucleotides du genome influenza a/udorn/72 (h3n2) Ceased WO2002000884A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2001270033A AU2001270033A1 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza A/Udorn/72 (H3N2) genome
IL15300501A IL153005A0 (en) 2000-06-23 2001-06-21 Nucleotide sequence of influenza a/udorn/72 (h3n2) genome
JP2002506199A JP2004514415A (ja) 2000-06-23 2001-06-21 インフルエンザＡ／Ｕｄｏｒｎ／７２（Ｈ３Ｎ２）ゲノムのヌクレオチド配列
BR0111819-6A BR0111819A (pt) 2000-06-23 2001-06-21 Moléculas de ácido nucléico isoladas, e, seq ência de aminoácido isolada
CA002410284A CA2410284A1 (fr) 2000-06-23 2001-06-21 Sequence de nucleotides du genome influenza a/udorn/72 (h3n2)
EP01948565A EP1292614A2 (fr) 2000-06-23 2001-06-21 Sequence de nucleotides du genome influenza a/udorn/72 (h3n2)
MXPA02012255A MXPA02012255A (es) 2000-06-23 2001-06-21 Secuencia de nucleotidos del genoma a/udorn/72(hen2) de influenza.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21365000P 2000-06-23 2000-06-23
US60/213,650 2000-06-23

Publications (2)

Publication Number Publication Date
WO2002000884A2 WO2002000884A2 (fr) 2002-01-03
WO2002000884A3 true WO2002000884A3 (fr) 2002-08-15

Family

ID=22795944

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/019826 Ceased WO2002000884A2 (fr) 2000-06-23 2001-06-21 Sequence de nucleotides du genome influenza a/udorn/72 (h3n2)

Country Status (10)

Country Link
EP (1) EP1292614A2 (fr)
JP (1) JP2004514415A (fr)
KR (1) KR20030013451A (fr)
CN (1) CN1437612A (fr)
AU (1) AU2001270033A1 (fr)
BR (1) BR0111819A (fr)
CA (1) CA2410284A1 (fr)
IL (1) IL153005A0 (fr)
MX (1) MXPA02012255A (fr)
WO (1) WO2002000884A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060160759A1 (en) * 2002-09-28 2006-07-20 Jianzhu Chen Influenza therapeutic
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
EP2295542B1 (fr) * 2004-12-24 2013-01-30 Abbott Biologicals B.V. Recupération du virus influenza
NZ562661A (en) * 2005-04-21 2010-04-30 Univ Florida Materials and methods for respiratory disease control in canines
EP2471805A3 (fr) 2005-05-06 2013-01-16 Gen-Probe Incorporated Compositions et procédés pour la détection spécifique d'acide nucléique des virus Influenza A ou B
US20100190842A1 (en) * 2007-04-12 2010-07-29 Alnylam Pharmaceuticals, Inc. Influenza polynucleotides, expression constructs, compositions, and methods of use
KR100913425B1 (ko) 2007-05-14 2009-08-21 녹십자수의약품(주) 인플루엔자 바이러스 및 그를 포함하는 면역원성 조성물
JP2012512633A (ja) 2008-12-19 2012-06-07 ヨーロピアン モレキュラー バイオロジー ラボラトリー エンドヌクレアーゼ活性を有するポリペプチド断片、及びそれらの使用
EP2593569B1 (fr) 2010-07-12 2018-01-03 Gen-Probe Incorporated Compositions et tests permettant de détecter l'acide nucleique du virus de la grippe a saisonniere h1
CN107488743A (zh) * 2017-08-30 2017-12-19 上海伯杰医疗科技有限公司 H3n2亚型流感病毒全基因组测序方法

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BISHOP D.H.L. ET AL.: "The complete sequence of RNA segment 2 of influenza A/NT/60/68 and its encoded P1 protein", NUCL. ACIDS RES., vol. 10, no. 4, 1982, pages 1335 - 1343, XP008003848 *
DE LA LUNA S. ET AL.: "Molecular cloning and sequencing of influenza virus A/VICTORIA/3/75 polymerase genes: sequence evolution and prediction of possible functional domains.", VIRUS RES., vol. 13, no. 2, 1989, pages 143 - 155, XP008003846 *
IUFEROV V.P. ET AL.: "[Nucleotide sequence of the hemagglutinin gene of the influenza virus A/UDORN/307/72 (H3N2)] (in Russian)", DOKLADY AKADEMII NAUK SSSR, vol. 278, no. 3, 1984, pages 738 - 742, XP008003843 *
LAWSON C.M. ET AL.: "Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus.", VIROLOGY, vol. 191, 1992, pages 506 - 510, XP002200635 *
MARKOFF L. & LAI C.J.: "Sequence of the influenza A/UDORN/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA.", VIROLOGY, vol. 119, no. 2, 1982, pages 288 - 297, XP008003845 *
OKAZAKI K. ET AL.: "Evolutionary pathways of the PA gnes of influenza viruses", VIROLOGY, vol. 172, no. 2, 1989, pages 601 - 608, XP008003844 *
PETROV N.A. ET AL.: "[Primary structure of the full-size DNA copy of the influenza virus A/KIEV/59/79 PB1 gene protein] (in Russian)", BIOORGANICESKAYA KHIMIYA, vol. 13, no. 9, 1987 - 2002, pages 1170 - 1175, XP008003847 *

Also Published As

Publication number Publication date
AU2001270033A1 (en) 2002-01-08
CN1437612A (zh) 2003-08-20
KR20030013451A (ko) 2003-02-14
MXPA02012255A (es) 2003-04-25
WO2002000884A2 (fr) 2002-01-03
BR0111819A (pt) 2004-01-06
CA2410284A1 (fr) 2002-01-03
JP2004514415A (ja) 2004-05-20
EP1292614A2 (fr) 2003-03-19
IL153005A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
WO2002000884A3 (fr) Sequence de nucleotides du genome influenza a/udorn/72 (h3n2)
ES2526191T3 (es) Método para producir virus influenza B infeccioso en cultivo celular
LU91367I2 (fr) Un vaccin à virus complet de l'influenza inactivéepréparé à partir d'une souche germe produite en u tlilisant la génétique inverse et facultativement comprenant un adjuvant
CA2154023A1 (fr) Virus recombinant infectieux a arn a brin negatif non segmente
DE69832624D1 (de) Hefestämme zur herstellung von milchsäure
BRPI0518568A2 (pt) mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico
EP1375652A3 (fr) Composition orale pour des sujets infectés par le VIH
EP2316924A3 (fr) Virus de polarité négative atténués dotés d'une activité antagoniste contre l'interféron altéré pour une utilisation en tant que vaccins et produits pharmaceutiques
AR029759A1 (es) Variante de glucoamilasa original, una construccion de adn, un vector de expresion recombinante, una celula, un proceso para convertir almidon, uso de una variante de glucoamilasa para un proceso de fermentacion y metodo para mejorar la estabilidad termica.
BR9904747A (pt) Microorganismo, e, processo para prodizir ácido l-glutâmico
BR9904449A (pt) Processo para o preparo de ácido pantotênico através de amplificação de sequências de nucleotìdeos, as quais codificam a redutase de cetopantoato
EP2527445A3 (fr) Traitement et prévention de la grippe
ATE553191T1 (de) Codon-optimierte alkalisch phosphatase und ihre expression in hefe
WO2002026979A1 (fr) NOUVELLE ENZYME PRESENTANT UNE ACTIVITE β-GLUCOSIDASE ET SON UTILISATION
WO1999004011A3 (fr) Antigenes du groupe o du vih-1 et leurs utilisations
ES2286212T3 (es) Secuencias suprimidas especificamente del genoma de mycobacterium tuberculosis, y su uso en el diagnostico y como vacunas.
GB0020331D0 (en) Enzyme
Schlesinger et al. Mechanisms involved in natural and experimental neuropathogenicity of influenza viruses: evidence and speculation
HUP0303878A2 (hu) Himlő elleni vakcina
DE60231821D1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
JP2007516721A5 (fr)
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
HUP0002022A2 (hu) Eljárás L-aminosavak fermentációs előállítására és az accDA-gént kódoló nukleotidszekvenciák
JP2004229537A5 (ja) 歯周病菌の定量方法
KR930018034A (ko) 트레할로오스의 제조방법

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2410284

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 153005

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001948565

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/012255

Country of ref document: MX

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 506199

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001270033

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020027017495

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 018116493

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020027017495

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001948565

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: 2001948565

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001948565

Country of ref document: EP